OP0142 Masking CD94/NKG2A using a novel therapeutic MAB results in significant suppression of IL-6 levels and reduced osteoclast formation in rheumatoid arthritis ex vivo cultures
Söderström K., Sundström Y., Berg L., Schepis D., Galsgaard ED., Klareskog L., Wagtmann N.